<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 30 Jan 2021 07:50:28 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Fiona Yu文章 l 从过去三年新药审批到Woodcock可能上位，看FDA的未来走向</title><link>https://mp.weixin.qq.com/s/lP6kt1ccOD2hRR-4a-vvzQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItbyqWYRaic0loVhahIpoS2ZFRPqPtuaAEhJ5ndg8aSjwzWhXAduK8ldfxluI2OFRnicLzvD2kgVaQA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>了解FDA审批的大趋势，更深刻地洞察行业的未来走向。]]></content:encoded><pubDate>Fri, 29 Jan 2021 22:56:05 +0800</pubDate></item><item><title>Vertex斥资10亿美元买下的干细胞衍生疗法治疗糖尿病进入临床开发阶段丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/jdaXI_ns8tmGd3JLq-MJLA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItbyqWYRaic0loVhahIpoS2ZVRz4ibEClJiaW41ZaKyr2xhhYZFwLB9ia0JicZJntHwmiaKaI2ib0aYokt6Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>干细胞治疗糖尿病]]></content:encoded><pubDate>Fri, 29 Jan 2021 22:56:05 +0800</pubDate></item><item><title>李氏大药厂PD-L1单抗被拟纳入突破性治疗品种，适应症为宫颈癌丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/dXY5KTvitfSt1pxmsG8L-Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItbyqWYRaic0loVhahIpoS2Z3fibQBibV7UhnKlXk2J9sw1dIf02lHedSoHGUS1AJIUhcnGFQHibyrGPQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有望成为首个被纳入突破性治疗品种的PD-L1]]></content:encoded><pubDate>Fri, 29 Jan 2021 22:56:05 +0800</pubDate></item><item><title>《2021基因行业蓝皮书》（预印版）正式公开发布，樊嘉院士/沈亦平/卢大儒/陆国辉等作序推荐</title><link>https://mp.weixin.qq.com/s/TzbSK19XvAkwiJnX3_A7Eg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItbyqWYRaic0loVhahIpoS2Z2CfPM0aztAylEr6dLQvVaJGfibEwSMUNLPM0dfSREBXdDNENFnv58zA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>内含电子版免费申请方式及读者福利]]></content:encoded><pubDate>Fri, 29 Jan 2021 22:56:05 +0800</pubDate></item><item><title>1年时间研发出来的新冠疫苗，到底安不安全？丨医麦新观察</title><link>https://mp.weixin.qq.com/s/2zdvapNGubtmU6tbFh1aSg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItbyqWYRaic0loVhahIpoS2ZibFNrKxdgadibyPv0X8Lp33Eu5EEVt9T9CXlpA7TWBb90Ud1IBDPGffw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>态度需谨慎，判断需合理]]></content:encoded><pubDate>Fri, 29 Jan 2021 10:22:47 +0800</pubDate></item><item><title>中国学者领衔胰腺癌新型治疗策略，全身给药溶瘤病毒显示出积极的临床前数据丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/GsbIUavSOSGAJfsDmAnGPg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIveHgB4VszBSlu5YwJwvt1wjysmuibUNeSxC3gLof1dVNx8qdKqWJMlKYAreZPndj2JyibIEib1ffziaw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>联合疗法攻克胰腺癌]]></content:encoded><pubDate>Fri, 29 Jan 2021 10:22:47 +0800</pubDate></item><item><title>百济神州高价收入的双特异性ADC公布积极数据，加速药物开发丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Xl8oOzX4l07XtNS_W8BfwQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItbyqWYRaic0loVhahIpoS2Zh7Wh3L1qHhgoPyb5klydWpzfvwthMfzm2ckbficTlvyW0M2oib17cK3Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>HER2靶点极具竞争力的ZW49]]></content:encoded><pubDate>Fri, 29 Jan 2021 10:22:47 +0800</pubDate></item><item><title>细胞治疗赛道火热​，商业化挑战和实体瘤上的应用需要更多思考丨峰客创见</title><link>https://mp.weixin.qq.com/s/BYlE8IfJVb7_O8B7SQpU3A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItbyqWYRaic0loVhahIpoS2ZjPfiasxxZRoQdn3uGxpw5x34BsHTSz82h7b4yLFI9ibKjaKwSPFYPHZQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>峰客访谈 · 创见专栏]]></content:encoded><pubDate>Fri, 29 Jan 2021 10:22:47 +0800</pubDate></item><item><title>诺华2020财报：细胞与基因疗法将成为未来的重磅炸弹，中国市场为诺华带来巨额收入丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/62n3jOxQ5Wg6Fmm8cib7mg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIu3HCL4gMgtH9oH8ksxYZT9Q6j9nAFHECMRuhHXl6LOeLKj5gb9ZDuxFYIU30FBEwZ1Q38ox0Oh3g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>首个公布2020年财报的跨国药企]]></content:encoded><pubDate>Wed, 27 Jan 2021 22:55:18 +0800</pubDate></item><item><title>更“聪明”的CAR设计，突破T细胞疗法在实体瘤中的瓶颈丨医麦黑科技</title><link>https://mp.weixin.qq.com/s/bZ_IZLrvFo6kpHWR67rLbQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIu3HCL4gMgtH9oH8ksxYZT9c00ljNXMXeFw4ib4HqvRjia3JP5dLFqaLefs4ymzGCHnHgQ5IYNuZAvg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>利用synNotch系统提高安全性和有效性]]></content:encoded><pubDate>Wed, 27 Jan 2021 22:55:18 +0800</pubDate></item><item><title>细胞治疗行业不能停留在同温层​，企业要争当行业龙头丨峰客创见</title><link>https://mp.weixin.qq.com/s/H79Cv1r0NzrNn6YL_BJYGg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIu3HCL4gMgtH9oH8ksxYZT9woiaNCjdibibAlOUCknSzQR4W9PbpbbjicPYhPepeZfO3KibwTBG0x9cMug/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>峰客访谈·创见专栏]]></content:encoded><pubDate>Wed, 27 Jan 2021 22:55:18 +0800</pubDate></item><item><title>药融资丨新锐细胞与基因治疗公司筹集550万美元融资，瞄准血管疾病</title><link>https://mp.weixin.qq.com/s/SWZm8khKPY8LAar6k7YJjw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mW6rQAOYFI5oXz7sUrjRDo3LZYgcMARnFNOLiaPwGyFjUIpJV1VNsEG9jzXplbSOZReKq5hZse6jXHF3gibBnhIQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>作为这项投资的一部分，Ambulero和Orphinic成立了波兰子公司Ambulero Sp. z o.o.]]></content:encoded><pubDate>Wed, 27 Jan 2021 22:55:18 +0800</pubDate></item><item><title>全球确诊病例破亿，BioNTech/复星医药对外公开新冠mRNA疫苗如何应对安全有效性、产能及运输问题丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/kxC7uJwNe1lQD-S1U0n5pg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIu3HCL4gMgtH9oH8ksxYZT9cmQa7ib9Er0klegOE4QQ4vE391DxYYxHLE1VbfoPByYAqXcs5WkFeTg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>发布会上解答了各类热点关注问题]]></content:encoded><pubDate>Wed, 27 Jan 2021 17:56:23 +0800</pubDate></item><item><title>Arrowhead递交RNAi疗法的IND申请，有望治疗混合血脂异常患者丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/vScdth1cz-Xf0gE9Kck8hg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIu3HCL4gMgtH9oH8ksxYZT9nfMYvgajcS8UMKac0CWpEZsw2AdLO6iccumCHDxQJ5k2aNxhNoz8uAw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>诺华已入局该研究领域]]></content:encoded><pubDate>Wed, 27 Jan 2021 17:56:23 +0800</pubDate></item><item><title>Cell子刊：靶向IRF4的ASO能够清除小鼠体内骨髓瘤细胞，提高存活率丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/U_SIExy4MQIR4xpLFhtmAg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIu3HCL4gMgtH9oH8ksxYZT9ZPh1Via0SqicmcTW8HibroY9nVH7Rp51tsb6QjSfP50Fe09V2WuUAYxwQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>多发性骨髓瘤的热门靶点]]></content:encoded><pubDate>Wed, 27 Jan 2021 17:56:23 +0800</pubDate></item><item><title>药融资丨诺华投资的TCR-T公司完成1亿美元C轮融资，推进TCR-T细胞疗法</title><link>https://mp.weixin.qq.com/s/8m9d1Q7OJZy58lgtbB6IVA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIs1WVZWh6BrLALW2dhZoAI5k69ic2RHV7CHwB9tOVUbLcGicxZ25rcZto7LfCXZNqeM60JVSDqndDVA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>迄今为止，该公司共募集超过1.8亿美元的资金]]></content:encoded><pubDate>Wed, 27 Jan 2021 17:56:23 +0800</pubDate></item><item><title>流式细胞术数据分析难？样本处理要求高？你离成为高手就差这个课程</title><link>https://mp.weixin.qq.com/s/o4s0vxb-KwzmJtPxlMfcLw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuaSn5kNicPBAAvg7d6IQ3wJQ57OI2j0Ps0V31ibz2qW2QudE1cjWSocLsfeO9DeWxicRicyLef6iaAndw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>流式技术并不难！2小时微课程带你进阶]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:41:01 +0800</pubDate></item><item><title>如何把握儿科临床研究关键挑战及应对策略 | 专家研讨会</title><link>https://mp.weixin.qq.com/s/wr7nOabw1kqLallMGO_dTQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuaSn5kNicPBAAvg7d6IQ3wJM8zqvkMyvkfFZgqClFsjPXq468Rn69pGc58icIEjGicGFRZD6MPzQBicg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>1月27日下午4点跟随专家解锁儿科研究更优方式，深究儿童临床研究实践中面临的挑战及应对策略]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:41:01 +0800</pubDate></item><item><title>复星医药m​RNA新冠疫苗获香港紧急使用认可，首批约100万剂预计2月下旬由德国抵港丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/zyb_JtNZTkNd9OTPV6Nr3Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuaSn5kNicPBAAvg7d6IQ3wJT7Xu2Yqd7Sdeglupoeut8XLhVEwQH2G9C7Zw5pRnhphUCsOiaG9vRpQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>复星医药负责中国开发，Ⅱ期临床已接种完毕]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:41:01 +0800</pubDate></item><item><title>抗体-寡核苷酸偶联物(AOC)即将进入临床阶段，用于治疗1型肌强直性营养不良丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/4hFTpq_lYfgmTwADCRFHqw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuaSn5kNicPBAAvg7d6IQ3wJjfjtLfYNOQQInUcO4ONJUX7S6ibATnn3OicldtOGNiaXzLXeRLr1U3vbg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>ADC引起了抗体偶联药物的研发热潮，细数各种抗体偶联策略]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:41:01 +0800</pubDate></item></channel></rss>